Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Mu-Hsin Chang

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Cancer Science|December 11, 2008
ERCC1 codon 118 C→T polymorphism associated with ERCC1 expression and outcome of FOLFOX-4 treatment in Asian patients with metastatic colorectal carcinomaPeter Mu-Hsin Chang, Cheng-Hwai Tzeng, Po-Min Chen, et al.
Biomed Research International|August 12, 2014
Cisplatin-based chemotherapy versus cetuximab in concurrent chemoradiotherapy for locally advanced head and neck cancer treatmentMing-Hung Hu, Ling-Wei Wang, Hsueh-Ju Lu, et al.
Cancer Chemotherapy and Pharmacology|April 13, 2011
Triweekly reduced-dose docetaxel combined with cisplatin in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase II studyPeter Mu-Hsin Chang, Cheng-Hwai Tzeng, Ming-Huang Chen, et al.
Biology|November 27, 2021
Computer-Aided Design for Identifying Anticancer Targets in Genome-Scale Metabolic Models of Colon CancerChao-Ting Cheng, Tsun-Yu Wang, Pei-Rong Chen, et al.
Cell Death Discovery|March 6, 2022
FAS receptor regulates NOTCH activity through ERK-JAG1 axis activation and controls oral cancer stemness ability and pulmonary metastasisLi-Jie Li, Peter Mu-Hsin Chang, Chien-Hsiu Li, et al.
International Journal of Molecular Sciences|February 13, 2025
Oral Cancer-Derived miR-762 Suppresses T-Cell Infiltration and Activation by Horizontal Inhibition of CXCR3 ExpressionHsuan-Yu Peng, Chia-Wei Chang, Ping-Hsiu Wu, et al.
Cancer Medicine|July 5, 2022
A generational comparison for unfavorable cancer of unknown primary in a single institute over 20 yearsCheng-Yu Tang, Jen-Fan Hang, Yi-Ping Hung, et al.
Journal of the Chinese Medical Association : JCMA|May 24, 2015
High neuroendocrine component is a factor for poor prognosis in gastrointestinal high-grade malignant mixed adenoneuroendocrine neoplasmsMing-Huang Chen, Ying-Ju Kuo, Yi-Chen Yeh, et al.
Journal of Hematology & Oncology|January 8, 2017
Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axisYu-Chan Chang, Li-Hsing Chi, Wei-Ming Chang, et al.
BMC Cancer|December 20, 2022
Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinomaTien-Hua Chen, Yi-Ying Pan, Tsung-Lun Lee, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Cancer Science|December 11, 2008
ERCC1 codon 118 C→T polymorphism associated with ERCC1 expression and outcome of FOLFOX-4 treatment in Asian patients with metastatic colorectal carcinomaPeter Mu-Hsin Chang, Cheng-Hwai Tzeng, Po-Min Chen, et al.
Biomed Research International|August 12, 2014
Cisplatin-based chemotherapy versus cetuximab in concurrent chemoradiotherapy for locally advanced head and neck cancer treatmentMing-Hung Hu, Ling-Wei Wang, Hsueh-Ju Lu, et al.
Cancer Chemotherapy and Pharmacology|April 13, 2011
Triweekly reduced-dose docetaxel combined with cisplatin in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase II studyPeter Mu-Hsin Chang, Cheng-Hwai Tzeng, Ming-Huang Chen, et al.
Biology|November 27, 2021
Computer-Aided Design for Identifying Anticancer Targets in Genome-Scale Metabolic Models of Colon CancerChao-Ting Cheng, Tsun-Yu Wang, Pei-Rong Chen, et al.
Cell Death Discovery|March 6, 2022
FAS receptor regulates NOTCH activity through ERK-JAG1 axis activation and controls oral cancer stemness ability and pulmonary metastasisLi-Jie Li, Peter Mu-Hsin Chang, Chien-Hsiu Li, et al.
International Journal of Molecular Sciences|February 13, 2025
Oral Cancer-Derived miR-762 Suppresses T-Cell Infiltration and Activation by Horizontal Inhibition of CXCR3 ExpressionHsuan-Yu Peng, Chia-Wei Chang, Ping-Hsiu Wu, et al.
Cancer Medicine|July 5, 2022
A generational comparison for unfavorable cancer of unknown primary in a single institute over 20 yearsCheng-Yu Tang, Jen-Fan Hang, Yi-Ping Hung, et al.
Journal of the Chinese Medical Association : JCMA|May 24, 2015
High neuroendocrine component is a factor for poor prognosis in gastrointestinal high-grade malignant mixed adenoneuroendocrine neoplasmsMing-Huang Chen, Ying-Ju Kuo, Yi-Chen Yeh, et al.
Journal of Hematology & Oncology|January 8, 2017
Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axisYu-Chan Chang, Li-Hsing Chi, Wei-Ming Chang, et al.
BMC Cancer|December 20, 2022
Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinomaTien-Hua Chen, Yi-Ying Pan, Tsung-Lun Lee, et al.
Pageof 10